Clinical Trials Browser

Phase 2 × pasireotide × Head & Neck × Clear all

NCT01270321 2021-02-17

Pasireotide & Everolimus in Adult Patients With Radioiodine-Refractory Differentiated & Medullary Thyroid Cancer

Phase 2 Completed

42 enrolled 11 charts

Thyroid Neoplasms